Market Brief — July 21, 2026

US equities advanced, with the Dow Jones Industrial Average (DJIA) up 0.7%, the S&P 500 (SPX) up 0.9%, and the Nasdaq Composite (^IXIC) up 1.3% as gains in technology and healthcare helped drive broad buying. In Europe, the CAC 40 (FRA40) rose 0.3%, the FTSE 100 (UKX) gained 0.6%, and the DAX (DAX) added 0.7% as investors reacted to supportive UK political developments and firm global risk appetite. Asian index data were unavailable for the session, leaving cross-regional sentiment to be guided mainly by US and European price action and macro headlines.

High-importance releases on the day included the UK unemployment rate for May, where previous readings were 4.9% and economist consensus clustered around 4.9–5.0%, and Germany's July ZEW Economic Sentiment Index, which had a prior level of 10.5 with forecasts between 7 and 18, while Japan's June trade balance was expected to widen to about ¥-700B from ¥-378.7B. Recent inflation data showed US CPI at 3.5% year-on-year and down 0.4% month-on-month, contrasting with India's June CPI at 4.38%, wholesale inflation near 9.87%, PMIs still expansionary around 54–57, and a trade deficit of roughly USD 15.31 billion. Analysts broadly expect the ECB to hold rates at its July meeting but keep the door open for another 25 bp hike by September as renewed Middle East tensions push Brent crude into the high $80s–$90 range, lift gold above $4,000/oz, and keep the US Dollar Index (DXY) near 101 with USD/JPY around 162.5 and 10-year Treasury yields near 4.59%.

President Trump signed proclamations imposing 50% tariffs on about $20 billion of Canadian goods under Section 338 of the Tariff Act, effective in 30 days, prompting warnings from Canadian officials and industry groups about higher costs and supply-chain disruption. In UK equities, John Healey's appointment as Chancellor supported defence names such as Babcock, BAE Systems, Rolls-Royce and QinetiQ, with reports estimating roughly £4 billion added to sector value and the FTSE 100 (UKX) gaining about 0.6%. Risk appetite in crypto and biotech stayed firm as bitcoin rose more than 2% toward $67,000 with a 3.5% 24-hour gain above $66,000 to the highest level in just over a month and Coinbase Global (COIN) shares climbed as much as 12.6% on optimism around the Clarity Act, while US biotech and pharma IPOs delivered a 55% weighted return year-to-date versus a 4.4% loss for the broader US IPO market and the Nasdaq Biotechnology Index up about 13%. GCG Advisory Partners reported a strong first half of 2026, completing four strategic acquisitions, adding about $1.1 billion in new assets and finalizing a three-platform advisory model. Announced transactions included Omio Group's plan to acquire Rail Europe to consolidate ground transportation, Veralto's acquisition of Alfaa UV to expand its ultraviolet water-treatment portfolio, and Siemens' agreement to buy Defacto Technologies to bolster automated SoC design capabilities. Additional deals saw Union Home Mortgage agree to acquire origination assets of AmeriTrust Mortgage, Arthur J. Gallagher & Co. move to buy W.N. Tuscano Agency, Native seek Frontline Research Group to build an AI data layer for African traditional trade, GrubMarket agree to buy Canadian online grocer SPUD, Einride target charging and energy software company Flipturn, and NFTE and BUILD announce a merger to drive systemic change in education.